News & Events about Treace Medical Concepts Inc.
TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who...
Treace Medical Concepts, Inc. (NASDAQ:TMCI Get Rating) Director James T. Treace sold 38,071 shares of the companys stock in a transaction dated Monday, January 30th. The shares were sold at an average price of $23.20, for a total transaction of $883,247.20. Following the sale, the director now ...
TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson...
Treace Medical Concepts, Inc. (NASDAQ:TMCI Get Rating) Director Richard W. Mott sold 42,467 shares of the stock in a transaction on Thursday, January 12th. The shares were sold at an average price of $26.00, for a total value of $1,104,142.00. Following the sale, the director now directly ...
Market News Video
24days ago
In trading on Thursday, shares of Treace Medical Concepts Inc (TMCI) touched a new 52-week high of 25.62/share. Thats a 105.29% rise, or 13.14 per share from the 52-week low of 12.48 set back on 05/10/2022...